Skip to main content

Table 2 Weighted prevalence of HPV and corresponding 95% confidence interval (CI) stratified by sample type

From: Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact

  Urine Self-taken swab LBC
HPV type Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI
Any HPV 32.2% (27.4, 37.0)% 39.5% (34.2, 44.9)% 49.4% (47.2, 51.5)%
HPV 16 or 18 10.0% (6.8, 13.1)% 16.6% (12.5, 20.7)% 23.0% (21.2, 24.8)%
HPV 31 or 33 or 45 or 51 9.3% (6.4, 12.3)% 13.5% (9.7, 17.3)% 19.1% (17.4, 20.8)%
Any high-risk HPV 19.1% (15.0, 23.1)% 29.1% (24.1, 34.1)% 41.2% (39.1, 43.4)%
High-risk excluding HPV 16 or 18 13.2% (9.8, 16.7)% 20.6% (16.2, 25.0)% 32.3% (30.2, 34.3)%
High-risk excluding HPV 16, 18, 31, 33, 45 or 51 8.0% (5.2, 10.8)% 11.2% (7.7, 14.7)% 21.5% (19.7, 23.2)%
  1. PTK samples were weighted by SIMD, specimen type and reminder status. LBC samples were weighted by SIMD.